Springboard Enterprises
Jennifer Lee serves as the Chief Executive Officer of JLC Life Sciences, LLC since July 2018, providing expertise in global clinical and regulatory strategy, business turnaround, and product development among other services. In addition, Jennifer holds several influential positions including Board of Director at Enzyme by Design, member of the Chicago Executive Board at How Women Lead, and venture partner at The Cancer Fund, which focuses on early-stage investments in cancer research. Jennifer has previously led oncology development at Radius Health, Inc., contributing to the FDA approval of ORSERDU™ during the pandemic. Educationally, Jennifer holds an M.S. in Clinical Research and Regulatory Administration from Northwestern University and a B.S. in Biochemistry from the University of Illinois Chicago.
This person is not in any offices
Springboard Enterprises
3 followers
Springboard's mission is to accelerate the growth of entrepreneurial companies led by women through access to essential resources and a global community of experts. We are a leading network of influencers, investors, and innovators dedicated to building companies at scale led by women who are transforming industries in technology and life science. The measure of our success is in the results. To date, Springboard's portfolio numbers 900 women-led companies, which have created $39.1 billion in value over the last 23 years. An outstanding 90% have raised capital, with 225 exits to strategic acquirers and 27 IPOs. The Springboard pipeline is full of current and rising 'unicorns' supported by a global network of domain and business scaling experts in the fields of drug development, therapeutics, medical devices, digital health, cybersecurity, AR/VR, retail, robotics, supply chain, AI applications, and renewable energy, among the many tech-driven solutions their innovators are bringing to market.